The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Humalog Mix25

100 unit(s)/millilitre Suspension for injection

Eli Lilly and Company LimitedEU/1/96/007/005

Main Information

Trade NameHumalog Mix25
Active SubstancesInsulin lispro
Strength100 unit(s)/millilitre
Dosage FormSuspension for injection
Licence HolderEli Lilly and Company Limited
Licence NumberEU/1/96/007/005

Group Information

ATC CodeA10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD04 insulin lispro


Licence Issued19/11/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back